The Radiation Oncology Registry and Biosample Repository

Last updated: February 25, 2025
Sponsor: Abramson Cancer Center at Penn Medicine
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neoplasms

Treatment

N/A

Clinical Study ID

NCT01577251
UPCC 11908
  • Ages > 18
  • All Genders

Study Summary

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Eligibility Criteria

Inclusion

  • Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy

  • Able to sign consent

Study Design

Total Participants: 8000
Study Start date:
June 01, 2008
Estimated Completion Date:
December 31, 2030

Connect with a study center

  • Virtua Samson Cancer Center

    Moorestown, New Jersey 08057
    United States

    Site Not Available

  • Virtua Health & Wellness Center

    Voorhees, New Jersey 08043
    United States

    Active - Recruiting

  • Lancaster General Hospital

    Lancaster, Pennsylvania 17604
    United States

    Active - Recruiting

  • Abramson Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania 19004
    United States

    Active - Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania 19104
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.